Rat (@RatCatDoge) header
Rat (@RatCatDoge) profile picture

maker of things, grateful, hobbit advocate, sometimes oracle

here, now
Joined July 2014
Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)Photo by Rat (@RatCatDoge)
Pinned Tweet
Objectively the greatest picture I have ever taken
1
5
653
This is disappointing to see. Blocking access to peptides through licensed pharmacies leaves patients with fewer regulated options and risks pushing them toward unregulated sources. Patients deserve a safe, legitimate path to care..not more barriers.
Kentucky won't be the only state to block these six peptides. HHS said it won't enforce federal law. It didn't touch state law, and pharmacy boards answer to state law. Where states stand today: 🔴 Kentucky: blocked 🔴 Ohio: BPC-157 already not allowed 🟡 Arizona, Illinois, Massachusetts: undecided 🟢 Utah: following HHS Most states haven't picked a side yet.
3
7
1
29
2,986
I genuinely don’t understand how the market is valuing $HIMS anymore. 😭 We’re talking about a company generating over $3 BILLION in annual revenue, yet its entire market cap is sitting around $3.7B. That’s barely 1.2× annual sales! And it’s not like HIMS has stopped growing. • Q3 revenue grew 49% YoY • Nearly 2.8 million subscribers • Expanding internationally • Launching new products and treatments • Building a global consumer healthcare platform Yes, margins have taken a hit, profitability needs improvement, and the recent earnings weren’t perfect. But are we seriously going to ignore billions in revenue and years of growth because of a few disappointing quarters? I’m not saying the stock can’t go lower. I’m just struggling to understand how much more negativity the market can possibly price into this company. $3B+ in revenue. $3.7B market cap. Something has to give eventually. $HIMS
9
4
54
6,001
They literally want you to get sick and die Don't Buy $HIMS and live instead
BREAKING: The American Medical Association (AMA) just asked the US government (HHS) to take back its plan to let pharmacies make BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV. If HHS listens, you won't be able to get them from a real pharmacy with a doctor's prescription. Only the gray market. And people are going to find a way to get peptides either way. All this letter decides is whether the guy buying BPC-157 gets it from a pharmacy or gray market. I'm not telling you the gray market is the answer. Testing, sterility, purity, etc. all of it matters. So if they really cared about your safety, they'd want him at the pharmacy. The truth is, your health was never in their best interest. These guys don't really care about you.
5
266
The market has produced 50+ negative narratives about $HIMS in the past few years and none have worked out This all emerges from the fact that $HIMS has going into a relatively minor investment cycle, which has distorted financials 16x gross profit in 6 years is extraordinary
11
12
188
16,510
2022 is widely acknowledged as a bear market, but notice how the net flow Z-score has surpassed 2022 levels multiple times in the past 4 years and has come close to it even more times. We've been in a bear market since 2022. The AI bull market hasn't even started.
Hedge funds have sold the techbottom once again
10
13
2
213
16,855
$HIMS bears on X: “Hims launched peptides without even having peptides.” 😭 I think people are overlooking the strategic reasoning behind the Peptides+ launch. There’s a massive difference between operating an independent longevity clinic and running a publicly traded healthcare platform serving millions of customers. Sermorelin has a history of FDA approval. Ipamorelin doesn’t. Considering everything Hims has experienced with GLP-1 regulatory challenges, is it really surprising that management might prioritize regulatory compliance over an aggressive initial rollout? Moreover, Hims has already announced plans to introduce BPC-157 and TB-500, subject to regulatory developments. The company isn’t just selling peptides. It’s building an integrated healthcare ecosystem encompassing: • Peptides and longevity treatments • Blood testing • Hormonal health • Personalized prescriptions • Ongoing clinical care Clinical criticism is absolutely welcome, but expecting a publicly traded healthcare company to introduce every experimental peptide on DAY ONE is unrealistic. Enter the market. Establish the infrastructure. Expand the portfolio as regulatory clarity improves. Scale. This is a product launch, not the finished product. The bigger picture matters. $HIMS 🐂
6
1
32
4,186
To be honest with you, I had no idea the modern stock market would test how much of a retarded pussy we all are individually at this level of intensity and practically several times per month Luckily, we have the right framework to respond and cooperate
Replying to @alc2022
Estoy cansado jefe
15
5
1
266
27,984
Former Netflix CFO and current $HIMS Lead Independent Director David B. Wells continues to strengthen his position in Hims & Hers. His shareholding journey: • Before May 26: 176,017 shares • May 26: 224,417 shares • June: 228,073 shares • November: 230,859 shares That’s a 31.16% increase in ownership in less than six months. He invested $1.17M of his own money in May, purchasing 48,400 shares at an average price of $24.235. Despite the massive sell-off: • Zero reported shares sold since the purchase. • ~$4.01M in total holdings at $17.37/share. • Continues to receive equity instead of cash director compensation. Insider conviction is worth paying attention to, especially when it comes from someone who chairs the company’s Audit Committee. $HIMS Source: SEC Form 4 filings.
🤖 Made with AI
3
11
114
7,691
when you define healthcare as more than just medication, you invite more people to find their own version of health. kudos to the entire uk team!
For many women, calories in, calories out doesn’t add up. Today, women in the UK can add more support from Hers Weight Loss, including: • Hers Metabolic Deep Dive. A free, 10-minute look at 100+ factors that could be making weight loss harder. • Hers Metabolic Health Test. An optional at-home blood test covering 24 markers, including cholesterol, HbA1c, and thyroid checks, plus hormones, inflammation, and markers linked to insulin resistance. • Care+. Extra support alongside a Hers weight loss plan, designed by women’s health experts. Read more: news.hims.com/newsroom/hers-…
28
12
337
17,128
$HIMS revenue is up a lot since 2020 The stock not so much
13
8
316
23,977
Wild price action market wide, but $HIMS is a once in a life time anomaly at this point Worst mispricing of a company since $TSLA pre 2020 Bought every single day the past 2 weeks and will continue until its back over $50, could easily happen before EOY
2
21
1,562
$ANT is trading over $1T market cap Meanwhile the combination of $HIMS and $NAUT can double your lifespan and both trade under $5B combined
2
452
There is no bubble
1
1
141
The seed of all fear in $HIMS started with hims house.
every $HIMS bullish should unfollow HimsHouse it is clear -> them are supporting other companies
11
2
65
8,158
$HIMS Peptides+ is here- “Sermorelin, NAD+, Glutathione, Vitamin B12, and L-Carnitine, depending on their needs as determined by their provider (now available). Access to BPC-157 and TB-500 will follow, consistent with regulatory standards.”
More than 10,000 people signed up for early access when we launched the waitlist two weeks ago for Peptides+. Starting today, they all have access to a comprehensive intake that will be the beginning of a journey with a provider to find whether a personalized treatment plan is right for them. Clinically-guided protocols. At-home blood collection. The full support of a care team that knows you, your progress, and your goals. And 5 US-compounded treatments, with more to come soon. It’s exactly what we think health should be: easy, personal, high-quality, supported by independent experts, and on the cutting edge of where science is going. We can’t wait to see where those journeys take you. Read more here, including important info: investors.hims.com/news/news…
3
5
74
3,652
$HIMS revenue up a lot since IPO Stock basically flat
28
23
6
671
55,878
> playing WoW > take a small break > check twitter > bitcoin under 69k > planes stopped working > another jensen affair > go back to playing WoW
137
749
45
13,844
253,135
$HIMS figured out how to get existing members to pay more (massive ARPU increase) And you are besrish? Retards
7
372
The ticker is $HIMS
This Post is from a suspended account. Learn more
16
1,609
[read about what’s happening with AI] ME: Wow we’re actually legit fucked this is so bad. [go outside] ME: Wait those people are all acting like nothing unusual is happening. Maybe I was just in a paranoid bubble? Yeah it must be that. Phew. [read more about what’s happening with AI] ME: Wait no we ARE fucked. Shit. It’s all those people outside who are in a delusional bubble. [go outside] ME: Wait...
372
1,009
184
14,599
723,261